Business Context and Reporting Period
Company: ALPHA PRO TECH LTD
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2007
Business Overview: Alpha Pro Tech develops, manufactures, and markets disposable protective apparel, infection control products, extended care products (medical bed pads, pet beds), and construction weatherization products. The company operates through four segments: Disposable Protective Apparel, Infection Control, Extended Care, and Engineered Products.
Key Financial Metrics (Year Ended Dec 31, 2007)
| Metric | 2007 | 2006 |
|---|---|---|
| Net Sales | $35,453,000 | $37,338,000 |
| Gross Profit | $16,442,000 | $17,320,000 |
| Gross Margin | 46.4% | 46.4% |
| Net Income | $2,417,000 | $3,739,000 |
| Diluted EPS | $0.09 | $0.15 |
| Cash and Equivalents | $4,064,000 | $1,837,000 |
| Working Capital | $22,669,000 | $19,618,000 |
| Total Debt | $0 | $0 |
| Current Ratio | 12.7:1 | 8.3:1 |
Material Changes vs. Prior Period
- Revenue Decline: Consolidated sales decreased 5.1% to $35.45 million. This was driven by a 32.9% drop in the Engineered Products segment (due to housing market downturn and distributor changes) and a 6.3% decline in Infection Control (reduced demand for N-95 masks as Avian Flu concerns abated). These were partially offset by a 6.6% increase in Disposable Protective Apparel sales.
- Profitability Compression: Net income fell 35.4% to $2.42 million. Income from operations dropped 42.6% to $3.41 million, primarily due to lower gross profit and a 14.7% increase in Selling, General, and Administrative (SG&A) expenses.
- Expense Increases: SG&A expenses rose to $12.54 million (35.4% of sales vs. 29.3% in 2006). Increases were attributed to the Engineered Products segment ($934,000), a $320,000 severance agreement, and higher marketing and travel costs.
- Liquidity Improvement: Despite lower earnings, cash and cash equivalents increased by $2.23 million to $4.06 million, driven by strong operating cash flow ($2.09 million) and proceeds from stock option exercises ($1.43 million).
Guidance, Outlook, and Risks
- Outlook: Management anticipates that the new distribution strategy for Engineered Products will broaden market opportunities in 2008. N-95 Respirator mask sales are expected to remain similar to 2007 levels unless global health concerns resurface. The Extended Care segment is not expected to be a growth driver.
- Key Risks:
- Customer Concentration: Sales to the largest distributor (VWR International) represented 45.1% of total sales in 2007. The loss of this customer would have a material adverse effect.
- Supply Chain: Significant reliance on a single third-party subcontractor in China for disposable protective apparel and a joint venture in India (Harmony Plastics) for Engineered Products.
- Market Conditions: The Engineered Products segment remains sensitive to the housing market and construction activity.
- Unusual Items: A $320,000 severance payment for a former Senior VP of Manufacturing was recorded in 2007. A $103,000 gain on a foreign currency exchange contract contributed to equity income from the unconsolidated affiliate.
Investor Verification Checklist
- Distributor Dependency: Verify the stability of the relationship with VWR International, which accounts for nearly half of all revenue.
- Engineered Products Turnaround: Assess the effectiveness of the new non-exclusive distribution strategy in reversing the 32.9% sales decline in this segment.
- Inventory Levels: Review the $1.4 million increase in inventory, particularly the $1.1 million buildup in the Engineered Products segment, to ensure it aligns with future sales expectations.
- SG&A Efficiency: Monitor whether SG&A expenses can be reduced as a percentage of sales given the revenue decline.
- Joint Venture Performance: Evaluate the financial health and repayment schedule of the Harmony Plastics joint venture in India.